Aldatu Biosciences Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Aldatu Biosciences develops adaptive PCR diagnostics to support global health and epidemic prevention, preparedness, and response. Our work focuses on overcoming the challenges posed by viral genetic diversity, particularly in low- and middle-income countries where diagnostic robustness and accessibility are critical.

Aldatu’s proprietary PANDAA platform enables sensitive and specific detection across genetically diverse pathogens, supporting reliable infectious disease testing in resource-limited settings. To date, Aldatu has secured more than $20 million in non-dilutive funding from the National Institutes of Health and operates under an ISO 13485–certified quality management system.

Sign up for free to view info

Company overview Employee directory